Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideo Shirafuji is active.

Publication


Featured researches published by Hideo Shirafuji.


Proceedings of the National Academy of Sciences of the United States of America | 2001

Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma

Atsushi Nakanishi; Shigeru Morita; Hiroki Iwashita; Yoji Sagiya; Yasuko Ashida; Hideo Shirafuji; Yukio Fujisawa; Osamu Nishimura; Masahiko Fujino

Airway hyperresponsiveness (AHR), goblet cell metaplasia, and mucus overproduction are important features of bronchial asthma. To elucidate the molecular mechanisms behind these pulmonary pathologies, we examined for genes preferentially expressed in the lungs of a murine model of allergic asthma by using suppression subtractive hybridization (SSH). We identified a gene called gob-5 that had a selective expression pattern in the airway epithelium with AHR. Here, we show that gob-5, a member of the calcium-activated chloride channel family, is a key molecule in the induction of murine asthma. Intratracheal administration of adenovirus-expressing antisense gob-5 RNA into AHR-model mice efficiently suppressed the asthma phenotype, including AHR and mucus overproduction. In contrast, overexpression of gob-5 in airway epithelia by using an adenoviral vector exacerbated the asthma phenotype. Introduction of either gob-5 or hCLCA1, the human counterpart of gob-5, into the human mucoepidermoid cell line NCI-H292 induced mucus production as well as MUC5AC expression. Our results indicated that gob-5 may play a critical role in murine asthma, and its human counterpart hCLCA1 is therefore a potential target for asthma therapy.


Agricultural and biological chemistry | 1979

Accumulation of Tripeptide Derivatives by Mutants of Cephalosporium acremonium

Hideo Shirafuji; Yukio Fujisawa; Makoto Kida; Toshihiko Kanzaki; Masahiko Yoneda

The two β-lactam antibiotics produced by Cephalosporium acremonium ATCC 14553, cephalosporin C and penicillin N, have been proposed to be biosynthesized through the peptide, δ-(l-α-aminoadipyl)-l-cystemyl-d-valine.Many β-lactam negative mutants were derived from the strain No. 52, which was a more potent producer of the β-lactam antibiotics than the parent strain, C. acremonium ATCC 14553. Some of them were found to accumulate two sulfur-containing peptides. These compounds were isolated from the culture filtrate of one of the mutants, N-2 and determined to be the dimer of δ-(l-α-aminoadipyl)-l-cysteinyl-d-valine and the S-methylthio derivative of the tripeptide.


Archives of Virology | 1971

Induction of interferon and host resistance in vivo by double-stranded complexes of copolyribonucleotide of inosinic and guanylic acids with polyribocytidylic acid

Shinobu Matsuda; Makoto Kida; Hideo Shirafuji; Masahiko Yoneda; Hideaki Yaoi

Several double-stranded complexes of copolyribonucleotide of inosinic and guanylic acids with polyribocytidylic acid (poly IG∶C) were found to possess interferon inducing activity stronger than poly I∶Cin vivo, Their activity increased in parallel with increase in the ratio of guanine base to hypoxanthine base in these copolymers as far as double-strand formation was observed with polyribocytidylic acid. Many other combinations of copolyribonucleotide with homopolyribonucleotide were also investigated, and several of them were found to induce interferon. However, the interferon inducing effects of these combinations including complementary base-pairings of hypoxanthine and cytosine increased in parallel with the length of the base-pairings, thus approaching to that of poly I∶C. It is, therefore, supposed that the activity of poly IG∶ C is somewhat different from poly I∶C and that those of other combinations owe to the essential structure of poly I∶C. Furthermore, kinetics of interferon induction, cross tolerance to reinduction, and antiviral effectsin vivo of poly IG∶C and poly I∶C were studied.


Agricultural and biological chemistry | 1969

Studies on the Guanosine Degrading System in Bacterial Cell:Part III. Purification and Properties of Guanosine Deaminase

Yasunari Ishida; Hideo Shirafuji; Makoto Kida; Masahiko Yoneda

A highly purified preparation of the enzyme, guanosine deaminase, has been obtained by a four-step purification procedure from the cells of Pseudomonas convexa No. 149. The enzyme deaminates guanos...


Journal of Medicinal Chemistry | 1995

Novel, Potent, and Orally Active Substance P Antagonists: Synthesis and Antagonist Activity of N-Benzylcarboxamide Derivatives of Pyrido[3,4-b]pyridine

Hideaki Natsugari; Yoshinori Ikeura; Yutaka Kiyota; Yuji Ishichi; Takenori Ishimaru; Osamu Saga; Hideo Shirafuji; Toshimasa Tanaka; Izumi Kamo


Biochemical and Biophysical Research Communications | 1999

Cloning and Expression of a Novel Lysophospholipase Which Structurally Resembles Lecithin Cholesterol Acyltransferase

Yoshio Taniyama; Sachio Shibata; Shunbun Kita; Kenichi Horikoshi; Hiromitsu Fuse; Hideo Shirafuji; Yasuhiro Sumino; Masahiko Fujino


Nature | 1973

New findings on cephalosporin C biosynthesis.

Yukio Fujisawa; Hideo Shirafuji; Makoto Kida; Kiyoshi Nara; Masahiko Yoneda; Toshihiko Kanzaki


Archive | 1986

A method for producing 2-keto-L-gulonic acid

Ikuo Nogami; Hideo Shirafuji; Masahide Oka; Takamasa Yamaguchi


Agricultural and biological chemistry | 1975

Accumulation of deacetylcephalosporin C by cephalosporin C negative mutants of Cephalosporium acremonium.

Yukio Fujisawa; Hideo Shirafuji; Makoto Kida; Kiyoshi Nara; Masahiko Yoneda; Toshihiko Kanzaki


Archive | 1988

Process for producing 2-keto-L-gulonic acid

Ikuo Nogami; Takamasa Yamaguchi; Masahide Oka; Hideo Shirafuji

Collaboration


Dive into the Hideo Shirafuji's collaboration.

Top Co-Authors

Avatar

Ikuo Nogami

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masahiko Yoneda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Takamasa Yamaguchi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Makoto Kida

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masahide Oka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yukio Fujisawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Toshihiko Kanzaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hideaki Natsugari

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Takenori Ishimaru

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Setsuo Harada

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge